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Magnetic resonance imaging with 
hyperpolarized [1,4-13C2]fumarate 
allows detection of early renal 
acute tubular necrosis
Clatworthy et al., Proc Natl Acad Sci USA advance online publication, 26 July 
2012, doi:10.1073/pnas.1205539109
Failure of drug treatment of acute kidney injury (AKI) is attrib-
uted, in part, to clinical trial design and the use of serum creatinine 
and blood urea nitrogen (BUN), which are nonspecific and late 
markers of AKI. The discovery and validation of novel urinary 
and serum biomarkers of kidney damage over the past decade 
represent major advances in the field of AKI. Imaging modalities 
may also be useful in the early and noninvasive diagnosis of AKI, 
but their development has lagged behind the development of bio-
chemical biomarkers. Clatworthy et al. investigated whether 13C 
magnetic resonance spectroscopic imaging (MRSI) might allow for 
the early diagnosis of AKI and whether it would be able to differen-
tiate acute glomerulonephritis (AGN) from acute tubular necrosis 
(ATN). 13C MRSI of hyperpolarized [1,4-13C2]fumarate and pyru-
vate was used in a murine model of AKI (folic acid (FA)-induced 
AKI) and AGN. Fumarate is excluded from viable cells, but not 
necrotic cells, where it undergoes conversion to malate. Pyruvate is 
a product of glycolysis and is reduced to lactate. [1,4-12C2]fumarate 
is thought to detect necrosis, and [1-413C]pyruvate is thought to 
detect inflammation. Eighteen hours after FA-induced injury, at a 
time when there was a rise in BUN and proteinuria, and minimal 
histological evidence of injury, a significant malate/pyruvate sig-
nal was observed. This ratio correlated with the extent of injury. 
Hyperpolarized [1,4-13C2]fumarate was not able to detect AGN. 
Hyperpolarized [1-13C]pyruvate did not detect ATN or AGN.
This study demonstrates the potential utility of a novel imag-
ing modality, MRSI of hyperpolarized [1,4-13C2]fumarate, for the 
early detection of ATN and differentiation from AGN. The early 
detection of AKI using this modality may be of value; however, 
thus far, other novel biochemical biomarkers have the ability to 
detect AKI much earlier than 18 hours. Nevertheless, this paper 
demonstrates an important advancement in the development of 
novel noninvasive tools for the diagnosis of AKI.
Mark Okusa
Genetically distinct subsets within 
ANCA-associated vasculitis
Lyons et al., N Engl J Med 2012; 367: 214–223; doi:10.1056/NEJMoa1108735
Anti-neutrophil cytoplasmic antibody (ANCA)-associated vas-
culitis is associated with significant morbidity and mortality. 
The two major syndromes are granulomatosis with polyangiitis 
(GPA) and microscopic polyangiitis (MPA). The pathogenesis 
is not fully understood, but ANCA may play a role. To examine 
genetic factors, a genome-wide association study was performed 
in 2687 patients with ANCA-associated vasculitis who were of 
European ancestry and 7650 matched controls. Major histo-
compatibility complex (MHC) and non-MHC associations with 
ANCA-associated vasculitis were found. The study confirmed 
associations with the HLA-DP region and with the serpin A1 
gene (SERPINA1), which encodes a1-antitrypsin, a protease 
inhibitor that inactivates proteinase 3. Further, the two subcate-
gories, GPA and MPA, showed distinct genetic backgrounds. The 
risk of MPA, and in particular myeloperoxidase ANCA positivity, 
is associated with the HLA-DQ locus (Figure).
This study confirms the genetic predisposition of ANCA-asso-
ciated vasculitis and the genetic distinctions between GPA and 
MPA and the pathogenic role of proteinase-3 ANCA. However, 
the study has some limitations: further clues as to the exact mech-
anism of how the polymorphisms lead to disease are lacking, and 
patients with Churg–Strauss syndrome were not included.
Jai Radhakrishnan
FGF23 neutralization  
improves chronic kidney disease–
associated hyperparathyroidism 
yet increases mortality
Shalhoub et al., J Clin Invest 2012; 122: 2543–2553; doi:10.1172/JCI61405
Serum levels of fibroblast growth factor 23 (FGF23) are strongly 
associated with mortality in patients with chronic kidney dis-
ease (CKD), and studies have suggested that elevated levels 
of FGF23 may contribute to organ complications in patients 
with CKD, including left ventricular hypertrophy and kid-
ney disease progression. There has, therefore, been intense 
interest in determining whether treatments targeting FGF23 
can improve clinical outcomes in patients with CKD. Shalhoub 
Relationships between clinical subtype and ANCA specificity in 
ANCA-associated vasculitis and associations of the MHC locus with 
proteinase 3 ANCA and myeloperoxidase ANCA. (a) Venn diagram 
shows the overlap between GPA or MPA and ANCA specificity (proteinase 
3 (PR3) or myeloperoxidase (MPO)) in the combined cohort. (b) −Log10 
P values for the association of single-nucleotide polymorphisms (SNPs) 
at the MHC locus in all ANCA-associated vasculitis patients. (c) PR3 
ANCA only. (d) MPO ANCA only. The gray vertical line (b–d) indicates the 
genomic location of the most associated SNP. The arrow (d) indicates 
the position of rs5000634 (HLA-DQ). (e) The genomic architecture of the 
MHC locus shows the recombination rates along the sequence as well. 
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et al. studied whether administration of low- or high-dose anti-
FGF23 antibodies could improve measures of CKD–mineral 
and bone disorder (CKD-MBD) and “associated comorbidities” 
in rats subjected to 5/6 nephrectomy (5/6Nx) and fed a high-
phosphate diet. As expected, 5/6Nx rats developed significantly 
reduced glomerular filtration rate and increased FGF23 lev-
els. Administration of rat anti-FGF23 resulted in significantly 
increased serum phosphorus and calcium levels and improved 
some CKD-MBD indices as reflected by increased 1,25-OH-
vitamin D, reduced parathyroid hormone, and improvement 
in histological bone disease. However, 5/6Nx rats treated with 
high-dose anti-FGF23 had increased risk of death, with 8 of 16 
rats dying during the 6-week study period (Figure). Admin-
istration of anti-FGF23 was also associated with worsening 
of histological CKD and a dose-dependent increase in aortic 
calcification in 5/6Nx rats. Moreover, there was no evidence 
for a beneficial effect of anti-FGF23 on development of cardiac 
hypertrophy, fibrosis, or inflammation in 5/6Nx rats.
Unlike most previous studies, this important study directly 
examined the effects of anti-FGF therapy in a preclinical model of 
CKD. Although the epidemiological studies to date had suggested 
that FGF23 may have a causative role in adverse clinical outcomes 
in patients with CKD, this study suggests that FGF23 is not simply 
a ‘uremic toxin,’ and it is even possible that elevated FGF23 levels 
may be, at least in part, an adaptive response to the deleterious 
effects of CKD. However, many questions remain unanswered, and 
future studies will need to determine whether the high-phosphate 
diet/hyperphosphatemia contributed to the deleterious effects of 
anti-FGF23 therapy, and to examine whether the effects of anti-
FGF23 therapy differ in an end-stage renal disease model where 
there may be less effect on renal phosphorus excretion.
Michael Ross
Hibris, a Drosophila nephrin 
homolog, is required for  
presenilin-mediated Notch  
and APP-like cleavages
Singh and Mlodzik, Dev Cell 2012; 23: 82–96; doi:10.1016/j.
devcel.2012.04.021
Notch transmembrane receptors are evolutionarily conserved 
proteins that bind with the extracellular domains of the ligands 
expressed on the surface of neighboring cells. Ligand–Notch 
interaction stimulates extracellular Notch cleavage by metal-
loproteinases followed by intracellular Notch cleavage by the 
g-secretase complex. The released Notch intracellular (Notch-
IC) domain then translocates to the nucleus, where it acti-
vates gene transcription. The process is known to influence a 
wide range of cellular processes, including cell proliferation, 
apoptosis, and cell adhesion. In glomerular podocytes, Notch 
activation has been shown to play an active role in proteinu-
ria. Transgenic mice that express activated Notch in podocytes 
have a reduced amount of nephrin, likely due to increased 
dynamin-dependent nephrin endocytosis. Consistently, podo-
cyte-specific deletion of molecules involved in canonical Notch 
signaling is able to prevent nephrin loss, and a protective effect 
of g-secretase inhibitors was demonstrated. Besides Notch acti-
vation, g-secretase cleaves amyloid precursor protein (APP). 
The enzyme is a multi-subunit protease complex consisting of 
four proteins: presenilin (Psn), nicastrin (Nct), APH-1 (ante-
rior pharynx-defective 1), and PEN-2 (presenilin enhancer 2), 
with Psn acting as the catalytic subunit. Elimination of pre-
senilin 1 in mammals leads to reduced g-secretase-mediated 
cleavage of APP and is implicated in the pathogenesis of Alz-
heimer’s disease. As for the kidney, APP was found enriched 
in podocytes, though its physiological function in these cells 
remains unknown. Singh and Mlodzik show an additional rel-
evant link between nephrin and presenilin-mediated cleavage 
of both Notch and APP. Through a series of in vitro and in 
vivo experiments, Hibris, the Drosophila ortholog of nephrin, 
is shown to interact with presenilin and other components of 
the g-secretase complex. Importantly, the authors show not 
only that Hibris is required for presenilin maturation, stabil-
ity, and cleavage, but also that the nephrin ortholog directly 
interacts with the Drosophila b-amyloid protein precursor-like 
(Appl), which is the ortholog of mammalian amyloid precursor 
protein (APP).
Therefore, besides confirming the link between nephrin and 
Notch, this work introduces a further role for nephrin in APP-
mediated pathways that could be relevant to mammalian podo-
cyte physiology and disease.
Maria Pia Rastaldi
Survival plot demonstrates higher mortality in the high-dose FGF23 
antibody (Ab) group. Started with normal + control Ab, normal diet (ND) 
(n = 10); sham-treated + control Ab, high-phosphate diet (HPD) (n = 12); 
5/6Nx + control Ab, HPD (n = 16); 5/6Nx + FGF23 Ab (3 mg/kg), HPD (n 
= 16); 5/6Nx + FGF23 Ab (10 mg/kg), HPD (n = 16). Note that the normal 
+ control Ab, ND, and sham-treated + control Ab groups’ results are 
superimposable at 100% survival throughout the 6-week treatment period.
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